Orciprenaline Has No Role in Mobitz Type II Block Management
Orciprenaline (isoproterenol) should not be used for Mobitz type II atrioventricular block, as this rhythm originates from structural disease in the His-Purkinje system below the AV node and requires pacing, not pharmacologic intervention. The definitive treatment is temporary followed by permanent pacemaker placement 1.
Why Orciprenaline Fails in Mobitz Type II Block
Anatomic Location Determines Treatment Response
- Mobitz type II block occurs in the His-Purkinje system (infranodal), not at the AV node level 1
- Beta-adrenergic agents like isoproterenol work primarily on the AV node, which is not the site of pathology in type II block 1
- Atropine (and by extension, sympathomimetics) are "unlikely to be responsive" and "preferably treated with transcutaneous pacing" in type II block 1
Evidence Against Pharmacologic Management
- One study showed isoproterenol improved His-Purkinje conduction in only 1 patient, with minimal effect on HV interval during sinus rhythm 2
- Paradoxically, isoproterenol can actually precipitate infra-Hisian AV block in susceptible patients 3
- The 2010 AHA guidelines explicitly state to "avoid relying on atropine in type II second-degree AV block" 1
Correct Management Algorithm for Mobitz Type II Block
Immediate Management (Symptomatic or Hemodynamically Unstable)
- Apply transcutaneous pacing immediately as Class II indication 1
- Do not delay pacing for pharmacologic trials 1
- Transcutaneous pacing serves as bridge to transvenous pacing 1
In Acute MI Context
- Temporary pacing indicated for medically refractory symptomatic bradycardia 1
- Observe waiting period before permanent pacemaker to assess for reversibility 1
- Permanent pacing indicated after waiting period for persistent Mobitz type II in acute MI 1
Definitive Management
- Permanent pacemaker is indicated regardless of symptoms in acquired Mobitz type II block not caused by reversible factors 1
- This is a Class I recommendation based on high risk of progression to complete heart block 1
Critical Pitfalls to Avoid
Misdiagnosis is Common
- Mobitz type II is frequently overdiagnosed; requires unchanged PR interval before and after the blocked beat 4
- Cannot diagnose type II from 2:1 AV block alone 1, 4
- Atypical Wenckebach can mimic type II block 4
- Vagal surges causing simultaneous sinus slowing and AV block can resemble type II but are benign 4
When Orciprenaline Might Be Mentioned (But Still Not for Type II)
- The drug label for orciprenaline actually describes orphenadrine citrate (a muscle relaxant with anticholinergic properties), not a beta-agonist 5
- One case report used orciprenaline to stabilize heart rate in complete AV block from lithium toxicity as bridge to pacing 6
- This was temporizing only; permanent pacemaker was still required 6
Reversible Causes Must Be Excluded
- Antipsychotic medications 7
- Tramadol and fentanyl combination 8
- Lithium toxicity (even at therapeutic levels) 6
- Acute MI with potential for resolution 1
Bottom Line
Mobitz type II block represents structural His-Purkinje disease requiring mechanical pacing intervention. Pharmacologic agents including orciprenaline/isoproterenol are ineffective because they cannot overcome infranodal conduction system pathology and may paradoxically worsen block 1, 2, 3. The only appropriate temporizing measure is transcutaneous pacing while arranging transvenous and ultimately permanent pacemaker placement 1.